Used as a key chiral intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs), particularly in the production of anti-inflammatory agents with improved gastrointestinal safety profiles. Its cyclopropane structure with specific stereochemistry enhances binding selectivity to cyclooxygenase (COX) enzymes, contributing to targeted therapeutic effects. Commonly employed in pharmaceutical research for developing analogs with optimized pharmacokinetic properties.